Sep 2026· Computational biology and chemistry· Vol 126 Pt 1, pp.
109427
· 0 citations· 47 references
Medicine
TL;DR
The findings suggest adamantane as a feasible backbone to develop anticancer agents which may act in-part via CDC25A interaction, suggest adamantane as a feasible backbone to develop anticancer agents which may act in-part via CDC25A.
Abstract
Various 2-fluorophenyl-adamantane analogs were studied to examine the potential for developing anticancer agents. This approach combined the synthesis of novel analogs spanning several structural variations, followed by in vitro cytotoxicity assessment, then computational studies utilizing network pharmacology, molecular docking, and density functional theory (DFT) techniques. 2-fluorophenyl-adamantanyl amides were synthesized by reacting a primary amine scaffold with the required acid chlorides. Anticancer activity was performed on PANC-1, DU145, A375, and MCF7 cells using a Sulforhodamine B colorimetric assay. IC50 values were determined to be as low as 0.53 µM for the most potent analog (AD-CA). Network pharmacology methods predicted biological targets including CDC25A enzyme. Molecular docking demonstrated binding within CDC25A. DFT calculations support the experimental findings by showing that AD-CA combines high nucleophilicity and electronic stability with a localized polar region around the chloroacetamide group. Molecular electrostatic potential and reduced density gradient (RDG) analyses further indicated favorable noncovalent interactions and limited steric congestion, consistent with its strong cytotoxic activity. Our findings suggest adamantane as a feasible backbone to develop anticancer agents which may act in-part via CDC25A interaction.
Promising compounds like SBB-2, SBB-3, SBB-5, SBB-6, and SBB-7 exhibit favourable physicochemical properties, high drug-likeness, solubility, and a non-toxic profile, making them strong candidates for further development of a promising drug.
D. Upadhyay, Drashti Thanki, C. Somaiya· Current Organic Synthesis· 0 citations
Inspired by the medicinally relevant stilbene scaffold, a series of six electronically tuned benzylidene-based Schiff base derivatives were designed, synthesized, and characterized by FT-IR, 1H NMR, 13C NMR, and ESI-MS analyses. The biological properties of the synthesized compounds were investigated through antioxidan...
K. Buran, E. Yıldırım, Nazmiye Öner et al.· Molecules· 0 citations
The results demonstrate the utility of target-hypothesis-guided design under conditions in which molecular target identity remains unresolved, and identify the highly cytotoxic bromoacetamide compound, comparable to doxorubicin.
K. O. Shibaeva, A. Smolobochkin, E. Chugunova et al.· International Journal of Mol...· 0 citations
Abstract This study details the rational design and synthesis of benzimidazole–1,2,3-triazole hybrids (10a-10o) as potential CDK2 inhibitors for anticancer treatment. Molecular docking showed strong binding within the ATP-binding site, with key hydrogen bonds to Leu83 and Asp86, as well as hydrophobic and π–π interacti...
Dharmesh A. Patel, R. Dabhi, Apurva Prajapati et al.· Synthetic Communications· 0 citations
The results indicate that structural modification of sulfadiazine through heterocyclic ring formation significantly enhances antibacterial activity and binding affinity, suggesting their potential as promising antimicrobial agents.
Rusul Zamil Abdulhassan, N. Majeed· Applied Chemistry for Engine...· 0 citations
INTRODUCTION
EF24, a synthetic curcumin derivative, is effective against different forms of cancers but its derivatives are underdeveloped, particularly to improve cytotoxicity and drug-receptor interactions in colorectal cancer.
AREAS COVERED
Nine N-benzoyl EF24 analogs were prepared and identified by Fourier transf...
Fatemeh Khademi Moughari, Ramin Ebrahimi Kiasari, G. Ghavami et al.· Future Medicinal Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.